Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism

Oncogene

Volumn 23, Issue 57, 2004, Pages 9269-9279

  Del Rincón, Sonia V ^a   Guo, Qi ^a   Morelli, Catia ^b   Shiu, Hoi Ying ^a   Surmacz, Eva ^c   Miller Jr , Wilson H ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALABRIA   (Italy)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; IRS 1; PKC; Retinoic acid; Ubiquitin

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; INSULIN RECEPTOR SUBSTRATE 1; LACTACYSTIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; RETINOIC ACID; SOMATOMEDIN C RECEPTOR; UBIQUITIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; HYDROLYSIS; IMMUNOPRECIPITATION; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRETINOIN; UBIQUITIN;

MINK CELL FOCUS-FORMING VIRUS;

EID: 11244280921     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208104     Document Type: Article

References (55)

1. Ando S, Panno ML, Salerno M, Sisci D, Mauro L, Lanzino M and Surmacz E. (1998). Bioch. Biophys. Res. Commun., 253, 315-319.
2. Blobe GC, Obeid LM and Hannun YA. (1994). Cancer Metast. Rev., 13, 411-431.
3. Boylan JM and Gruppuso PA. (2002). Endocrinology, 143, 4178-4183.
4. Boyle JO, Langenfeld J, Lonardo F, Sekula D, Reczek P, Rusch V, Dawson MI and Dmitrovsky E. (1999). J. Natl. Cancer Inst., 91, 373-379.
5. Brouillard F and Cremisi CE. (2003). J. Biol. Chem., 278, 39509-39516.
6. Buren J, Liu HX, Jensen J and Eriksson JW. (2002). Eur. J. Endocrinol., 146, 419-429.
7. Burks DJ and White MF. (2001). Diabetes, 50, S140-S145.
8. Chan TW, Pollak M and Huynh H. (2001). Clin. Cancer Res., 7, 2545-2554.
9. Chang Q, Li Y, White MF, Fletcher JA and Xiao S. (2002). Cancer Res., 62, 6035-6038.
10. Chernov MV, Bean LJ, Lerner N and Stark GR. (2001). J. Biol. Chem., 276, 31819-31824.
11. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
12. del Rincón SV, Rousseau C, Samanta R and Miller Jr WH. (2003). Oncogene, 22, 3353-3360.
13. Dow R, Hendley J, Pirkmaier A, Musgrove EA and Germain D. (2001). J. Biol. Chem., 276, 45945-45951.
14. Egawa K, Nakashima N, Sharma PM, Maegawa H, Nagai Y, Kashiwagi A, Kikkawa R and Olefsky JM. (2000). Endocrinology, 141, 1930-1935.
15. Gonzalez C, Alonso A, Grueso NA, Diaz F, Esteban MM, Fernandez S and Patterson AM. (2001). J. Pancreas, 2, 140-149.
16. Greene MW, Morrice N, Garofalo RS and Roth RA. (2004). Biochem. J., 378, 105-116.
17. Greene MW, Sakaue H, Wang L, Alessi DR and Roth RA. (2003). J. Biol. Chem., 278, 8199-8211.
18. Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM and Kobayashi M. (2000). Mol. Endocrinol., 14, 783-794.
19. Hirashima Y, Tsuruzoe K, Kodama S, Igata M, Toyonaga T, Ueki K, Kahn CR and Araki E. (2003). J. Endocrinol., 179, 253-266.
20. Huang X, Vaag A, Hansson M and Groop L. (2002). J. Clin. Endocrinol. Metab., 87, 255-259.
21. Ito T, Sasaki Y and Wands J. (1996). Mol. Cell. Biol., 16, 943-951.
22. Iwao K, Kawasaki H, Taira K and Yokoyama KK. (1999). Nucleic Acids Symp. Ser., 42, 207-208.
23. Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb DK, Parmar S, Giafis N, Kalvakolanu DV, Rahman A, Uddin S, Minucci S, Tallman MS, Fish EN and Platanias LC. (2003). J. Biol. Chem., 278, 32544-32551.
24. Kim HJ and Lotan R. (2004). Cancer Res., 64, 2439-2448.
25. Langenfeld J, Kiyokawa H, Sekula D, Boyle J and Dmitrovsky E. (1997). Proc. Natl. Acad. Sci. USA, 94, 12070-12074.
26. Lavan BE, Lane WS and Lienhard GE. (1997). J. Biol. Chem., 272, 11439-11443.
27. Lee AV, Gooch JL, Oesterreich S, Guler RL and Yee D. (2000). Mol. Cell. Biol., 20, 1489-1496.
28. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK and Yee D. (1999). Mol. Endocrinol., 13, 787-796.
29. Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, Holmberg L and Bergh J. (2004). Carcinogenesis, 25, 375-380.
30. Molloy CA, May FE and Westley BR. (2000). J. Biol. Chem., 275, 12565-12571.
31. Morelli C, Garofalo C, Bartucci M and Surmacz E. (2003). Oncogene, 22, 4007-4016.
32. Rechsteiner M and Rogers SW. (1996). Trends Biochem. Sci., 21, 267-271.
33. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng Cn, Lee AV and Yee D. (1997). Clin. Cancer Res., 3, 103-109.
34. Rosenauer A, Nervi C, Davison K, Lamph WW, Mader S and Miller Jr WH. (1998). Cancer Res., 58, 5110-5116.
35. Rosenauer A, Raelson JV, Nervi C, Eydoux P, DeBlasio A and Miller Jr W. (1996). Blood, 88, 2671-2682.
36. Salerno M, Sisci D, Mauro L, Guvakova MA, Ando S and Surmacz E. (1999). Int. J. Cancer, 81, 299-304.
37. Shepherd PR, Withers D and Siddle K. (1998). Biochem. J., 333, 471-490.
38. Smith LK, Bradshaw M, Croall DE and Garner CW. (1993). Biochem. Biophys. Res. Commun., 196, 767-772.
39. Spinella MJ, Freemantle SJ, Sekula D, Chang JH, Christie AJ and Dmitrovsky E. (1999). J. Biol. Chem., 274, 22013-22018.
40. Sueoka N, Lee HY, Walsh GL, Hong WK and Kurie JM. (1999). Cancer Res., 59, 3838-3844.
41. Sun H, Tu X, Prisco M, Wu A, Casiburi I and Baserga R. (2003). Mol. Endocrinol., 17, 472-486.
42. Sun XJ, Goldberg JL, Qiao LY and Mitchell JJ. (1999). Diabetes, 48, 1359-1364.
43. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ and White MF. (1991). Nature, 352, 73-77.
44. Surmacz E and Burgaud JL. (1995). Clin. Cancer Res., 1, 1429-1436.
45. Tanaka T, Rodriguez de la Concepcion ML and De Luca LM. (2001). Biochem. Pharmacol., 61, 1347-1355.
46. Treier M, Staszewski LM and Bohmann D. (1994). Cell, 78, 787-798.
47. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B and Baserga R. (2002). J. Biol. Chem., 277, 44357-44365.
48. Turnbow MA, Keller SR, Rice KM and Garner CW. (1994). J. Biol. Chem., 269, 2516-2520.
49. van der Burg B, van der Leede BM, Kwakkenbos-Isbrucker L, Salverda S, de Laat SW and van der Saag PT. (1993). Mol. Cell. Endocrinol., 91, 149-157.
50. Wang LM, Myers Jr MG, Sun XJ, Aaronson SA, White M and Pierce JH. (1993). Science, 261, 1591-1594.
51. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. (1994). Nature, 369, 669-671.
52. White MF. (1997). Diabetologia, 40, S2-S17.
53. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T. (1996). Cancer Res., 56, 2945-2948.
54. Zhande R, Mitchell JJ, Wu J and Sun XJ. (2002). Mol. Cell. Biol., 22, 1016-1026.
55. Zhang H, Hoff H and Sell C. (2000). J. Biol. Chem., 275, 22558-22562.